According to a report by Asiae on July 30th, South Korean tobacco company KT&G and Philip Morris International (PMI) have reached a new business cooperation memorandum of understanding (MOU) to launch a new HNB e-cigarette "NGP" in the US market and apply for sales approval.
This collaboration marks the two companies jointly submitting a Pre-Market Tobacco Product Application (PMTA) for this e-cigarette product to the U.S. Food and Drug Administration (FDA). Additionally, KT&G and PMI will also closely collaborate in the regulatory review of Next Generation Products (NGP).
Prior to this, KT&G and PMI established a partnership in January of last year (2023) to promote the commercialization of KT&G's NGP products in overseas markets.
KT&G's CEO Bang Kyung-Man stated,
The company is currently focusing on three core businesses: NGP, overseas cigarettes, and health functional foods, actively promoting global expansion and structural transformation. KT&G is committed to achieving its vision of becoming a top global enterprise by innovating NGP products and utilizing scientific research and development capabilities.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
